Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Ekin Pellegrini has lofty goals as president of the Executive DBA Council
Pellegrini’s fascinating life and career path, from Turkey to UMSL with several stops along the way, has prepared her to lead the Executive DBA Council.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- Ekin Pellegrini has lofty goals as president of the Executive DBA Council
- UMSL receives INSIGHT Into Diversity magazine’s Higher Education Excellence in Diversity Award for the fifth straight year
- Associate Professor Emerita Chikako Usui honored by Japanese government for outstanding contribution to Japan-U.S. relations
- UMSL partnering with World Wide Technology to offer educational opportunities to employees looking to move forward in their careers
- Helena Marvin, Lori Curtis and Daniel Gerth receive UMSL Hero Awards
- Community members gather to celebrate 30 years of Greek Studies at UMSL
- Eye on UMSL: Work in progress
- Provost Steven Berberich announces 17 faculty promotions for the 2024-25 academic year
- UMSL Tritons weekly rewind
- Ken and Nancy Kranzberg receive 2024 E. Desmond and Mary Ann Lee Medal for Philanthropy at Founders Celebration
